Evidence map›Paper›PMID 24421794›Full record

ArticleThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2013

Risk of cytomegalovirus infection and disease after umbilical cord blood transplantation in children.

Pierre Alex Crisinel, Michel Duval, Delphine Thuillard Crisinel, Brigitte Mallette, Nathalie Bellier, Marie-France Vachon, Laurence Dedeken, Céline Rousseau, Bruce Tapiero, Philippe Ovetchkine

Open access · goldAbstract read
In one paragraph

Article in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Cytomegalovirus in Haematological Tumours.Frontiers in immunology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Pierre Alex CrisinelInfectious Diseases Division, Université de Montréal, Montréal, Québec;
Michel DuvalOnco-Hematology Division, Université de Montréal, Montréal, Québec;
Delphine Thuillard CrisinelInfectious Diseases Division, Université de Montréal, Montréal, Québec;
Brigitte MalletteDepartment of Microbiology and Immunology CHU Ste-Justine - Université de Montréal, Montréal, Québec.
Nathalie BellierOnco-Hematology Division, Université de Montréal, Montréal, Québec;
Marie-France VachonOnco-Hematology Division, Université de Montréal, Montréal, Québec;
Laurence DedekenOnco-Hematology Division, Université de Montréal, Montréal, Québec;
Céline RousseauDepartment of Microbiology and Immunology CHU Ste-Justine - Université de Montréal, Montréal, Québec.
Bruce TapieroInfectious Diseases Division, Université de Montréal, Montréal, Québec;
Philippe OvetchkineInfectious Diseases Division, Université de Montréal, Montréal, Québec;
Université de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPediatric data regarding cytomegalovirus (CMV) infections in pediatric patients receiving umbilical cord blood (UCB) transplantation are sparse.

objectiveTo determine whether UCB transplantation increases the risk of CMV infection and disease compared with other graft sources.

methodsThe medical files of patients who underwent allogeneic hematopoietic stem cell transplantation at CHU Ste-Justine (Montreal, Quebec) from April 2000 to December 2006 were retrospectively reviewed. A Cox proportional hazard model was used to assess the effect of potential predictors of outcomes.

resultsA total of 176 patients with a median age of nine years (range 0.1 to 18 years) underwent hematopoietic stem cell transplantation. The source of stem cells were UCB, bone marrow and peripheral blood stem cells in 86, 86 and four of the cases, respectively. CMV infection occurred in 29 patients (16%). At day 100 post-transplantation, the rate of CMV infection was 13% in UCB transplant recipients (11 of 86) versus 20% in those with other sources of graft (18 of 90) (P=0.19). Positive CMV serology of the recipient and leukocyte depletion were two independent variables associated with an increased risk of CMV infection. Among infected patients, six developed CMV disease (20.7%). The rate of CMV disease one year after infection was 49% in patients who received UCB (five of 11) and 6% in others (one of 18). This difference was significant by univariate (P=0.01) but not by multivariate analysis.

conclusionIn the setting of the current study, with a moderate CMV infection rate (16.5%), UCB transplantation did not appear to increase the risk of CMV infection and disease.

Indexed as

ChildrenCytomegalovirusHematopoietic stem cell transplantUmbilical cord blood

Identifiers

PMID24421794
PMCPMC3630031
OpenAlexW1444186680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.